Philip Morris International, IBM Launch Industry-Focused Systems Biology Verification Challenge | GenomeWeb

By Bernadette Toner

Tobacco giant Philip Morris International is partnering with IBM in an effort to advance the industrial applications of systems biology and computational modeling.

The initiative, called Industrial Methodology for Process Verification in Research, or IMPROVER, kicked off this week with the Diagnostic Signature Challenge — the first of several challenges planned over the next four years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.